Virtus LifeSci Biotech Clinical Trials ETF Rating $19.85 -0.34 (-1.68%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$19.99 +0.14 (+0.71%) As of 06/13/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.93Holdings in BBC have an aggregate rating of Moderate Buy based on 1,079 analyst ratings issued in the past year covering 122 companies (98.4% of the portfolio).BBC Aggregate Price Target$19.85High Prediction$19.85Average Prediction$19.85Low Prediction$19.85Holdings in BBC have an aggregate price target of $19.85 and a range of $19.85 to $19.85 covering 122 companies (98.4% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy68 Buy rating(s)Moderate Buy45 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 100 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.90%AKROAkero Therapeutics$55.62+3.8%3.6067 of 5 stars3.00$82.50 48.3%7Trending NewsInsider TradeGap DownHigh Trading Volume1.78%SLNOSoleno Therapeutics$79.15-1.3%4.7465 of 5 stars3.11$106.78 34.9%9Positive NewsAnalyst RevisionGap Down1.67%LQDALiquidia$14.10-2.4%3.6927 of 5 stars3.00$26.89 90.7%9Analyst ForecastOptions Volume1.62%XERSXeris Biopharma$4.35-1.6%3.886 of 5 stars2.83$6.25 43.7%61.58%ANABAnaptysBio$23.32-0.4%1.6228 of 5 stars2.80$42.38 81.7%10Positive News1.57%CVACCureVac$5.57-0.5%4.281 of 5 stars2.67$9.00 61.6%3Trending NewsAnalyst ForecastOptions VolumeGap DownHigh Trading Volume1.54%MRUSMerus$54.61-1.4%3.0613 of 5 stars3.13$85.83 57.2%151.40%MLYSMineralys Therapeutics$14.32-4.0%2.7488 of 5 stars2.75$32.25 125.2%4Positive NewsAnalyst Forecast1.40%ETNB89bio$10.41+8.2%2.4953 of 5 stars3.00$26.43 153.9%8News CoveragePositive NewsAnalyst ForecastAnalyst RevisionGap UpHigh Trading Volume1.37%ITOSiTeos Therapeutics$10.17+1.9%3.739 of 5 stars2.14$15.86 55.9%7Insider Trade1.35%PTGXProtagonist Therapeutics$56.37+0.1%1.9881 of 5 stars3.00$65.44 16.1%9Insider Trade1.35%TSHATaysha Gene Therapies$2.54-4.2%3.8091 of 5 stars3.00$7.57 198.1%8Analyst ForecastAnalyst RevisionGap Down1.29%RGNXREGENXBIO$9.27-9.1%4.2847 of 5 stars2.83$31.63 241.2%6Gap Down1.20%ARQTArcutis Biotherapeutics$13.43-0.5%1.8792 of 5 stars2.83$18.80 40.0%6Positive NewsGap Up1.17%SANASana Biotechnology$2.59+2.0%1.9144 of 5 stars2.86$10.80 317.0%7Positive News1.16%MNMDMind Medicine (MindMed)$7.17-1.8%1.9129 of 5 stars3.27$25.50 255.6%11Positive NewsAnalyst Revision1.12%BLTEBelite Bio$59.55-4.2%2.7956 of 5 stars3.00$96.67 62.3%4Positive NewsShort Interest ↑Analyst Revision1.11%KYMRKymera Therapeutics$46.96-0.7%3.1704 of 5 stars3.00$59.82 27.4%18Gap Down1.09%ORICORIC Pharmaceuticals$9.63-0.4%3.8505 of 5 stars3.00$19.17 99.0%8News CoverageAnalyst Revision1.08%CMPSCOMPASS Pathways$4.39-2.9%2.4964 of 5 stars3.00$18.83 329.0%6Positive NewsGap Down1.08%SMMTSummit Therapeutics$19.78-1.9%3.047 of 5 stars2.77$35.09 77.4%13Analyst UpgradeAnalyst RevisionGap Down1.07%RNAAvidity Biosciences$31.37-2.4%1.9259 of 5 stars3.07$67.33 114.6%15Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionGap Down1.05%QUREuniQure$15.34-4.1%2.0753 of 5 stars2.91$37.82 146.5%11Analyst DowngradeAnalyst RevisionGap Down1.03%ABUSArbutus Biopharma$3.53-1.4%2.2204 of 5 stars3.00$5.50 55.8%4Positive News1.03%LENZLENZ Therapeutics$29.00-2.0%1.6426 of 5 stars3.17$46.60 60.7%6Positive News1.02%EYPTEyePoint Pharmaceuticals$9.03+1.9%2.1963 of 5 stars3.00$25.38 181.0%9Analyst RevisionGap Down1.00%CELCCelcuity$12.11-3.6%1.9071 of 5 stars3.17$30.80 154.3%6Positive News1.00%CGONCG Oncology$25.86-2.4%2.4563 of 5 stars3.00$58.22 125.1%11Positive NewsAnalyst RevisionGap Down1.00%ZYMEZymeworks$12.67-3.3%1.8464 of 5 stars2.90$21.00 65.7%10Positive NewsGap Down0.98%RVMDRevolution Medicines$40.59-1.3%4.422 of 5 stars3.00$67.08 65.3%12Positive News0.97%NUVLNuvalent$78.24+0.4%2.1636 of 5 stars2.90$115.50 47.6%100.97%TNGXTango Therapeutics$4.69-7.1%2.1188 of 5 stars3.00$12.20 160.1%6Trending NewsAnalyst RevisionGap Down0.97%NUVBNuvation Bio$1.73-4.7%2.95 of 5 stars3.17$7.83 354.1%6News CoverageAnalyst ForecastHigh Trading Volume0.94%PHVSPharvaris$16.70-3.1%1.3979 of 5 stars3.00$36.20 116.8%5Analyst ForecastAnalyst Revision0.94%SLNSilence Therapeutics$5.33-4.7%2.8407 of 5 stars2.71$33.83 534.8%7News CoveragePositive NewsAnalyst ForecastGap Up0.92%AVBPArriVent BioPharma$23.27-1.5%1.4643 of 5 stars3.14$39.29 68.8%7Positive NewsHigh Trading Volume0.91%ELVNEnliven Therapeutics$21.91+11.4%2.4707 of 5 stars3.00$37.25 70.0%4News CoverageInsider TradeGap DownHigh Trading Volume0.90%IDYAIDEAYA Biosciences$22.18-0.4%3.851 of 5 stars2.93$54.27 144.7%14Analyst RevisionGap Down0.89%SNDXSyndax Pharmaceuticals$10.25-3.9%2.9323 of 5 stars2.91$35.91 250.3%11News Coverage0.89%APGEApogee Therapeutics$44.48+6.3%2.393 of 5 stars3.00$94.60 112.7%5Positive NewsGap DownHigh Trading Volume0.88%IMTXImmatics$6.12-0.3%2.5965 of 5 stars3.20$14.67 139.7%5Analyst Revision0.87%STOKStoke Therapeutics$11.53-2.5%3.644 of 5 stars3.29$23.20 101.2%7Analyst Revision0.87%KROSKeros Therapeutics$13.56-0.6%3.6179 of 5 stars2.50$30.56 125.3%14Analyst DowngradeGap Down0.86%CNTACentessa Pharmaceuticals$12.38+2.8%3.6346 of 5 stars3.00$27.89 125.3%10Positive News0.86%NGNENeurogene$19.76-3.1%3.4758 of 5 stars2.71$45.40 129.8%7News CoverageAnalyst ForecastGap Down0.85%REPLReplimune Group$9.78-1.1%4.5172 of 5 stars3.14$20.83 113.0%7Positive NewsGap Down0.84%VERVVerve Therapeutics$6.16-2.5%2.2784 of 5 stars3.00$25.75 318.0%6Gap Down0.84%VRDNViridian Therapeutics$15.88+1.3%1.7889 of 5 stars2.90$37.56 136.5%10Positive NewsGap Down0.83%MLTXMoonLake Immunotherapeutics$44.21+0.4%2.0511 of 5 stars3.00$78.71 78.0%8Analyst Revision0.83%TRMLTourmaline Bio$19.68-1.1%2.84 of 5 stars3.00$49.33 150.7%7Positive NewsAnalyst RevisionGap Down0.83%XENEXenon Pharmaceuticals$32.76-0.1%3.6625 of 5 stars3.00$54.82 67.3%12Options VolumeAnalyst Revision0.82%CLDXCelldex Therapeutics$21.26+4.5%2.6411 of 5 stars2.90$50.90 139.4%10Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.82%NAMSNewAmsterdam Pharma$20.21-3.9%2.9609 of 5 stars3.00$43.00 112.8%7Positive NewsAnalyst ForecastAnalyst Revision0.81%IRONDisc Medicine$53.71+1.9%2.1639 of 5 stars3.09$96.70 80.0%11Analyst ForecastAnalyst RevisionHigh Trading Volume0.81%DNTHDianthus Therapeutics$18.31-5.1%1.371 of 5 stars3.13$53.00 189.5%8Analyst Revision0.81%ARWRArrowhead Pharmaceuticals$15.74-3.0%3.5931 of 5 stars2.75$43.71 177.7%8Analyst UpgradeAnalyst Revision0.81%ACLXArcellx$66.00-0.8%2.7862 of 5 stars3.07$111.33 68.7%14Insider TradeAnalyst RevisionGap Down0.79%ABCLAbCellera Biologics$3.20+1.6%2.4631 of 5 stars2.75$8.33 160.4%4News CoverageOptions VolumeGap DownHigh Trading Volume0.79%ARCTArcturus Therapeutics$12.38-2.1%3.2096 of 5 stars3.11$53.50 332.1%9Positive NewsAnalyst RevisionGap Down0.78%SRRKScholar Rock$32.45-2.6%4.3808 of 5 stars3.14$42.67 31.5%7Gap Down0.78%SVRASavara$2.21-2.2%2.0549 of 5 stars2.67$7.17 224.3%6Gap Down0.78%CGEMCullinan Therapeutics$8.61-3.8%1.6855 of 5 stars3.00$30.00 248.4%5Analyst Forecast0.77%AUTLAutolus Therapeutics$2.12-1.4%2.5609 of 5 stars3.00$9.32 339.6%5News CoveragePositive NewsAnalyst ForecastGap Up0.77%CAPRCapricor Therapeutics$11.78-15.5%2.2546 of 5 stars3.00$35.50 201.4%6Analyst ForecastOptions VolumeAnalyst RevisionGap Down0.77%VERAVera Therapeutics$22.74+1.0%2.8835 of 5 stars3.10$65.00 185.8%10Short Interest ↑Analyst RevisionGap Up0.75%IMNMImmunome$9.20-6.0%1.6186 of 5 stars3.00$23.33 153.6%6News CoveragePositive NewsGap Down0.75%GPCRStructure Therapeutics$21.68-2.4%2.427 of 5 stars3.00$76.50 252.9%7News CoverageAnalyst RevisionGap Down0.75%CATXPerspective Therapeutics$3.17-1.6%2.8326 of 5 stars3.20$12.63 298.3%10Analyst Revision0.74%MREOMereo BioPharma Group$2.76-0.7%1.6925 of 5 stars3.17$7.67 177.8%6Positive NewsAnalyst Revision0.74%VIRVir Biotechnology$5.222.9889 of 5 stars2.86$32.86 529.4%7Positive NewsGap Down0.73%COGTCogent Biosciences$7.08-1.9%2.3003 of 5 stars2.75$14.57 105.8%8News CoveragePositive NewsGap Down0.72%RLAYRelay Therapeutics$3.22-6.7%2.2076 of 5 stars2.83$17.67 448.7%12Positive NewsGap Up0.71%KURAKura Oncology$6.44-3.3%4.3532 of 5 stars2.93$24.50 280.4%14Analyst Revision0.71%OLMAOlema Pharmaceuticals$4.17+2.7%2.5271 of 5 stars3.00$24.50 487.5%4Positive NewsGap Down0.70%SYRESpyre Therapeutics$17.29-2.4%2.4045 of 5 stars3.25$53.40 208.8%8Positive NewsGap Down0.70%MBXMBX Biosciences$10.37-3.3%2.0119 of 5 stars3.00$37.50 261.6%6Gap Up0.69%TYRATyra Biosciences$10.43+1.0%2.0558 of 5 stars3.00$30.83 195.6%6Positive NewsGap Down0.68%RXRXRecursion Pharmaceuticals$4.92-4.8%1.9289 of 5 stars2.33$7.60 54.5%6Analyst RevisionGap DownHigh Trading Volume0.68%CYTKCytokinetics$34.38+3.6%4.268 of 5 stars2.93$70.92 106.3%15Analyst Revision0.68%ALLOAllogene Therapeutics$1.34-4.3%3.8395 of 5 stars2.90$8.44 530.2%10Positive NewsGap Down0.67%ALTAltimmune$6.92-3.2%2.5481 of 5 stars3.00$20.20 191.9%7Analyst DowngradeGap Down0.65%DNLIDenali Therapeutics$14.55-2.5%4.335 of 5 stars3.06$33.71 131.7%17Positive NewsAnalyst RevisionGap Down0.64%NRIXNurix Therapeutics$11.93-0.3%2.2422 of 5 stars2.83$30.18 152.9%18Gap Down0.63%GLUEMonte Rosa Therapeutics$4.91-0.2%2.2878 of 5 stars2.75$15.50 215.7%40.63%BEAMBeam Therapeutics$17.06-2.2%3.0661 of 5 stars3.00$48.75 185.8%15Analyst RevisionGap Down0.62%CRNXCrinetics Pharmaceuticals$31.77-1.2%3.5221 of 5 stars2.91$74.56 134.7%11Positive NewsAnalyst RevisionGap Down0.61%PRAXPraxis Precision Medicines$44.30-1.6%2.7652 of 5 stars2.80$109.90 148.1%10Positive NewsAnalyst Forecast0.61%IMVTImmunovant$15.66-1.8%1.5085 of 5 stars2.90$38.33 144.8%10Analyst Revision0.60%BCAXBicara Therapeutics$10.84-6.3%2.0571 of 5 stars3.00$31.86 193.9%9Analyst Revision0.59%FDMT4D Molecular Therapeutics$4.39-2.4%2.8651 of 5 stars2.60$29.56 573.2%10Positive NewsAnalyst ForecastAnalyst Revision0.59%ERASErasca$1.48-3.3%2.7303 of 5 stars3.00$4.57 208.9%7Positive NewsGap Down0.59%VKTXViking Therapeutics$26.08-8.7%4.3993 of 5 stars3.00$87.15 234.2%14News CoverageOptions VolumeAnalyst RevisionGap Down0.58%RCUSArcus Biosciences$9.25-1.1%2.2661 of 5 stars2.90$24.13 160.8%10Options VolumeAnalyst RevisionGap Up0.57%NTLAIntellia Therapeutics$8.31-0.5%4.5958 of 5 stars2.67$34.95 320.6%21Positive NewsAnalyst RevisionGap Down0.57%EWTXEdgewise Therapeutics$15.29-0.8%2.6529 of 5 stars2.78$39.78 160.2%9Gap Up0.54%TERNTerns Pharmaceuticals$3.88-1.3%4.12 of 5 stars2.60$15.63 302.7%5Positive NewsGap Down0.54%TECXTectonic Therapeutic$21.89-2.5%3.287 of 5 stars3.25$82.33 276.1%8Analyst ForecastGap Down0.54%RAPPRapport Therapeutics$11.19+0.4%1.9513 of 5 stars3.00$32.67 191.9%4Positive News0.54%RNACCartesian Therapeutics$10.42+1.8%1.8707 of 5 stars2.71$43.00 312.7%7Positive NewsAnalyst RevisionGap Down0.54%DYNDyne Therapeutics$14.41-0.3%2.4414 of 5 stars3.00$44.93 211.8%15Positive NewsAnalyst ForecastGap Down This page (NYSEARCA:BBC) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.